Business Context and Reporting Period
This Form 8-K Current Report was filed by First Hawaiian, Inc. on December 6, 2022. The filing addresses corporate governance changes, specifically the expansion of the Board of Directors and the appointment of a new director.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial figure disclosed relates to director compensation:
- Director Compensation: A one-time award of restricted stock units valued at $26,603 was granted to the newly appointed director.
Material Changes
The primary material change reported is the increase in the size of the Board of Directors from nine to ten members. Mark Mugiishi, M.D., F.A.C.S. was appointed to fill the new vacancy effective immediately. Dr. Mugiishi was also appointed to the Risk Committee of the Board and to the board of directors of First Hawaiian Bank, a wholly owned subsidiary.
Outlook, Risks, and Contingencies
Related Party Transactions: The filing discloses a potential conflict of interest regarding Dr. Mugiishi's material interest in Hawaii Medical Service Association (HMSA). HMSA holds loans from First Hawaiian Bank made in the ordinary course of business on terms comparable to those for unrelated persons, with no indication of increased risk of collectibility.
Management Commentary: The filing highlights Dr. Mugiishi's extensive background, including his role as President and CEO of HMSA since 2020 and his prior experience as a general surgeon and medical director.
Investor Verification Checklist
- Verify the impact of the Board expansion on corporate governance and committee structures.
- Review the terms of the restricted stock unit award granted to Dr. Mugiishi.
- Confirm the status and terms of loans held by HMSA with First Hawaiian Bank to ensure continued compliance with related-party transaction policies.
- Check for any subsequent filings regarding Dr. Mugiishi's voting record or committee assignments.